Interleukin-8 Promoter Polymorphism -251 A/T and Treatment Response in Neovascular Age-related Macular Degeneration.
Alexander Kai ThomsenMarie Krogh NielsenCharlotte LiisborgTorben Lykke SørensenPublished in: Clinical ophthalmology (Auckland, N.Z.) (2024)
The IL-8 polymorphism -251 A/T is not associated to morphological nor functional treatment response to intravitreal anti-VEGF injections in patients with nAMD.